Evolent Health, Inc. Total Assets

• Evolent Health, Inc. showed a decrease of -25.4% in Total Assets from 2024 to 2025.
• This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: $1.04 billion | Q3 2015: $1.06 billion | Q1 2016: $856.46 million | Q2 2016: $852.80 million | Q3 2016: $851.28 million | Q1 2017: $1.15 billion | Q2 2017: $1.14 billion | Q3 2017: $1.30 billion | Q1 2018: $1.31 billion | Q2 2018: $1.32 billion | Q3 2018: $1.32 billion | Q1 2019: $1.63 billion | Q2 2019: $1.65 billion | Q3 2019: $1.71 billion | Q1 2020: $1.45 billion | Q2 2020: $1.27 billion | Q3 2020: $1.39 billion | Q1 2021: $1.31 billion | Q2 2021: $1.29 billion | Q3 2021: $1.25 billion | Q1 2022: $1.34 billion | Q2 2022: $1.30 billion | Q3 2022: $1.76 billion | Q1 2023: $2.59 billion | Q2 2023: $2.65 billion | Q3 2023: $2.67 billion | Q1 2024: $2.64 billion | Q2 2024: $2.48 billion | Q3 2024: $2.50 billion | Q1 2025: $2.65 billion | Q2 2025: $2.46 billion | Q3 2025: $2.45 billion.
• Over the full 12 years of available data (2014 to 2025), Evolent Health, Inc.'s Total Assets has grown by 5,005.1%.
• Historical annual values: Fiscal year 2025: $1.90 billion | Fiscal year 2024: $2.54 billion | Fiscal year 2023: $2.68 billion | Fiscal year 2022: $1.82 billion | Fiscal year 2021: $1.42 billion | Fiscal year 2020: $1.37 billion | Fiscal year 2019: $1.50 billion | Fiscal year 2018: $1.72 billion | Fiscal year 2017: $1.31 billion | Fiscal year 2016: $1.20 billion | Fiscal year 2015: $1.02 billion | Fiscal year 2014: $37.20 million.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026